84 related articles for article (PubMed ID: 964711)
1. [Activation of the immune system and remission period in malignant lymphomas].
Havemann K; Schultz H
Hamatol Bluttransfus; 1976; 18():329-38. PubMed ID: 964711
[No Abstract] [Full Text] [Related]
2. Delay in progression of malignant lymphoma after BCG vaccination.
Sokal JE; Aungst CW; Snyderman M
N Engl J Med; 1974 Dec; 291(23):1226-30. PubMed ID: 4609380
[No Abstract] [Full Text] [Related]
3. Cellular immune responses and prognosis in malignant lymphomas.
Sokal JE; Aungst CW
Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
[No Abstract] [Full Text] [Related]
4. Vinblastine treatment of malignant lymphomas.
Klener P; Donner L; Neuwirtová R; Ort J
Neoplasma; 1971; 18(5):505-11. PubMed ID: 4940935
[No Abstract] [Full Text] [Related]
5. Use of vinblastine for maintenance therapy in malignant lymphomas.
Klener P; Donner L; Ort J
Neoplasma; 1974; 21(3):323-9. PubMed ID: 4608740
[No Abstract] [Full Text] [Related]
6. [Adjuvant chemotherapy in malignant lymphomas].
Obrecht JP
Haematol Blood Transfus; 1978; 22():89-100. PubMed ID: 374201
[No Abstract] [Full Text] [Related]
7. Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas.
Advani SH; Gangal SG; Gopal R; Nair CN; Dinshaw KA; Desai PB
Indian J Med Res; 1985 Mar; 81():306-12. PubMed ID: 4018861
[No Abstract] [Full Text] [Related]
8. [Combination chemotherapy in malignant lymphoma. Results of long-term follow-up].
Kimura I; Ohnoshi T; Ueoka H; Nishihara R
Rinsho Ketsueki; 1985 Jun; 26(6):831-40. PubMed ID: 4068248
[No Abstract] [Full Text] [Related]
9. Complex radiation-chemotherapy of malignant lymphomas in combination with nonspecific BCG-immunostimulation. A preliminary report.
Marinov L
Panminerva Med; 1976; 18(5-6):162-6. PubMed ID: 1264470
[No Abstract] [Full Text] [Related]
10. [Immunity, leukemias and lymphomas. 3. Immune reactions in malignant granuloma in relationship to the clinical stage of the disease].
Danieli G; Malini PL; Montroni M; Cremonini G; Lauria F; Tura S
G Clin Med; 1972 Apr; 53(4):179-95. PubMed ID: 4651225
[No Abstract] [Full Text] [Related]
11. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
[No Abstract] [Full Text] [Related]
12. Immune deficiency in malignant lymphomas.
Konopka L; Pawelski S; Maślanka K; Zupańska B; Cieśluk S
Chemioterapia; 1987 Jun; 6(2 Suppl):745-8. PubMed ID: 3509538
[No Abstract] [Full Text] [Related]
13. [Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
Viollier AF; Senn HJ
Schweiz Med Wochenschr; 1976 May; 106(22):730-42. PubMed ID: 996491
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy in lymphoma.
Alexanian R
Arch Intern Med; 1975 Jan; 135(1):62-6. PubMed ID: 1089397
[TBL] [Abstract][Full Text] [Related]
15. [BCG vaccination in the treatment of malignant non-Hodgkin lymphomas].
Gociu M; Ciocoiu A; Moţoiu I; Drăghici D; Dumitrescu A; Costescu M; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):25-8. PubMed ID: 6145202
[No Abstract] [Full Text] [Related]
16. [The so-called partial synchronization in the treatment of malignant lymphomas. A clinical study].
Höche D; Fink R; Anger G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):13-26. PubMed ID: 6157615
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphomas at the Pathology Department, University of Khartoum, Sudan.
Ahmed MA; Omer A; el Hassn AM
East Afr Med J; 1984 Aug; 61(8):627-31. PubMed ID: 6336041
[No Abstract] [Full Text] [Related]
18. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
19. [Classification of malignant lymphomas and the relationship between histopathological aspects and clinical course].
van Unnik JA; Somers R
Ned Tijdschr Geneeskd; 1975 Jun; 119(25):981-7. PubMed ID: 1143584
[No Abstract] [Full Text] [Related]
20. [The role of vinblastine in the treatment of malignant lymphomas].
Eridani S; Esposito R; Ponti GB; Giangrande A
Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
[No Abstract] [Full Text] [Related]
[Next] [New Search]
